Heimdall Insights

Global Ankylosing Spondylitis Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Ankylosing Spondylitis Market was valued at $6.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.6% CAGR, to an estimated market size of $9.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The market encompasses pharmaceuticals, biologics, and biosimilars used for the treatment of Ankylosing Spondylitis, a chronic inflammatory condition primarily affecting the axial skeleton. The scope includes various drug classes such as TNF inhibitors, IL-17 inhibitors, NSAIDs, and JAK inhibitors, while excluding non-pharmacological physical therapy and surgical interventions.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Ankylosing Spondylitis Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • TNF Inhibitors
  • IL Inhibitors
  • NSAIDs
  • JAK Inhibitors & Others